"The price of medicines is the basic lever for the price. When the price of Chinese medicine is too low and the cost is not enough, it will easily lead to cutting corners." Said during the interview.

With regard to the current status of drug bidding, Zhong Nanshan has some concerns: “I think that the basic lever of price when selecting drugs for bidding is actually very dangerous. For Chinese medicine, as far as I know, if the bidding price is not enough even if the cost price is not enough, actually When drugs are used, it is possible to cut corners, and the quality is difficult to guarantee. It is not difficult to obtain qualified certification when bidding, but it is difficult to say afterwards.”

“In terms of Banlangen, there are many homes in the country, but Banlangen in “Baiyunshan” does have a good reputation for quality, but it also has a high cost, so when it comes to drug bidding prices, it should be comprehensively measured, rather than simply looking at the conformity certification. Afterwards, whoever has the lowest prices will be recruited.” Zhong Nanshan said that blindly “price levers” may hurt ethnic medicine, and it is advisable to invite experts, industry insiders, etc., to establish reasonable prices based on costs, and to bid on this basis. In addition, the drug bidding system needs to be further improved.

As for the entry of Chinese medicine in the EU, Zhong Nanshan said, “I think the West does not accept Chinese medicine. It is not because of its effective and ineffective considerations. It is a concern about quality issues. Many Chinese medicines are effective and I am now The use of Chinese medicine to treat irregular heartbeats has been less and less frequent after a while, and we are also conducting an in-depth study. It has been done for three years and found that Radix Isatidis contains active ingredients that can protect human cells from viruses. There may be similar antibiotics, especially when the disease is used early, and it works well.”